Oncotarget · 2016 · 21 citations · 20 references
MedicineOncologyOtolaryngologyCarcinogenesisNeoplasiaTumor ImmunologyThyroid CancerThyroid SurgeryAutoimmune Thyroid Disease TestingDifferentiated Thyroid Cancer DiagnosisDifferentiated Thyroid Carcinoma SurgeryPrognostic Factors AnalysisThyroid AutoantibodiesThyroid Cancer RiskThyroid ExaminationThyroid Functional Imaging
// Chao Li 1, * , Wenbin Yu 2, * , Jinchuan Fan 1 , Guojun Li 3, 4 , Xiaofeng Tao 5 , Yun Feng 6 , Ronghao Sun 1 1 Department of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China 2 Department of Head and Neck surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China 3 Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 4 Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 5 Department of Radiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 6 Department of Otorhinolaryngology Head & Neck Surgery, China-Japan Friendship Hospital, Beijing, China * These authors have contributed equally to this work Correspondence to: Yun Feng, email: fjfengyun2007@hotmail.com Ronghao Sun, email: sunronghao666@163.com Keywords: differentiated thyroid carcinoma, thyroid functional parameters, thyroid correlative autoantibodies, prognostic factors Received: May 24, 2016 Accepted: June 13, 2016 Published: June 23, 2016 ABSTRACT To evaluate the effect of preoperative thyroid functional parameters and thyroid autoantibodies on aggressive clinicopathologic features and lymph node metastasis (LNM) of differentiated thyroid cancer patients. Four hundred twenty consecutive patients with initial surgery were enrolled from July 2010 to July 2015. The associations between aggressive clinicopathologic and LNM factors and thyroid functional & autoantibodies parameters were analyzed. Higher levels of TSH, TGAb or TMAb were found in patients with tumor size≥1 cm (all P <0.05), especially when TSH≥2.5 ulU/ml ( P =0.03) and TGAb≥1 ( P =0.01). Higher levels of TSH and TGAb and lower levels of T3 and T4 were found in patients with capsular invasion (all P <0.05), particularly when TSH≥2.5ulU/ml ( P =0.03) and TGAb≥1 ( P =0.005). The patients with multifocality had higher TAbs level (TAbs>1). Higher level of TSH was also found in patients with central LNM ( P =0.001) and lateral LNM ( P =0.002), especially with TSH≥2.5ulU/ml ( P =0.003 and P =0.03). TGAb level was also found higher in patients with central LNM ( P =0.02) and lateral LNM ( P =0.01), especially with TGAb≥1 ( P <0.05 and P =0.01). Higher level of TMAb was found in patients with lateral LNM (P<0.05). Moreover, multivariable analysis revealed that only TGAb was an independently predictive factor for primary tumor size≥1cm ( P =0.01); and TSH level ( P =0.01) and TGAb≥1 ( P <0.05) were associated independently with central LNM. Thus, TSH level and TGAb≥1 were significantly independent predictors for central LNM, and might help make the decision of central neck dissection.
20
Ian Hay, Erik J. Bergstralh, John R. Goellner et al. · PubMed · 1993 · 1.2K citations
Emilio Fiore, Teresa Rago, M A Provenzale et al. · Endocrine Related Cancer · 2009 · 249 citations · Full text
Thenmalar Vadiveloo, Peter T. Donnan, Lynda Cochrane et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 191 citations